BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
67.96
+1.82 (2.75%)
Oct 6, 2026, 11:19 AM EDT - Market open
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +76.57% | Oct 6, 2026 |
| Barclays | Barclays | Buy Maintains $157 | Buy | Maintains | $157 | +131.02% | Sep 30, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $110 | Buy | Reiterates | $110 | +61.86% | Sep 24, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $130 | Buy | Maintains | $130 | +91.29% | Sep 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $96 → $110 | Buy | Maintains | $96 → $110 | +61.86% | Aug 31, 2026 |
| Jefferies | Jefferies | Buy Maintains $110 | Buy | Maintains | $110 | +61.86% | Aug 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $115 | Buy | Maintains | $115 | +69.22% | Aug 31, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $110 | Buy | Maintains | $110 | +61.86% | Aug 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.